Home › Head and Neck Squamous Cell Carcinoma › North Dakota › Bismarck
Head and Neck Squamous Cell Carcinoma clinical trials in Bismarck, ND
5 studies for Head and Neck Squamous Cell Carcinoma are looking for participants at sites in and around Bismarck (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
High-dose Prophylactic Gabapentin (HOPE) vs. Placebo to Prevent Opioid Use for Oral Mucositis Pain During Concurrent Chemoradiation for Head and Neck Cancer
RecruitingPhase 3
- Sanford Bismarck Medical Center, Bismarck
Testing the Addition of Anti-Cancer Drug, Cetuximab, to Standard of Care Treatment (Pembrolizumab) for Returning or Spreading Head and Neck Cancer After Previous Treatment
RecruitingPhase 3
- Sanford Bismarck Medical Center, Bismarck
BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study
RecruitingPhase 2
- Sanford Bismarck Medical Center, Bismarck
Testing What Happens When an Immunotherapy Drug (Pembrolizumab) is Given by Itself Compared to the Usual Treatment of Chemotherapy With Radiation After Surgery for Recurrent Head and Neck Squamous Cell Carcinoma
RecruitingPhase 2
- Sanford Bismarck Medical Center, Bismarck
Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery
RecruitingPhase 2
- Sanford Bismarck Medical Center, Bismarck
Head and Neck Squamous Cell Carcinoma trials in other cities
- Houston, TX47 studies
- Los Angeles, CA42 studies
- Boston, MA40 studies
- New York City, NY39 studies
- Nashville, TN39 studies
- St. Louis, MO28 studies
- Arlington, VA26 studies
- Chicago, IL26 studies
- Philadelphia, PA26 studies
- Atlanta, GA24 studies
- San Antonio, TX22 studies
- Pittsburgh, PA22 studies
Other studies in Bismarck
- Lung Cancer9 studies
- Non-Small Cell Lung Cancer6 studies
- Breast Cancer3 studies
- Pancreatic Cancer3 studies
- Rectal Cancer3 studies
- Colon Cancer3 studies
- Prostate Cancer3 studies
- Hypopharyngeal Cancer3 studies
- Laryngeal Cancer3 studies
- Oral Cancer3 studies
- Colorectal Cancer3 studies
- Melanoma3 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.